XML 48 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - PROPERTY AND EQUIPMENT (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 01, 2017
USD ($)
Apr. 02, 2015
USD ($)
Oct. 31, 2013
USD ($)
Sep. 30, 2017
USD ($)
Mar. 31, 2017
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2017
USD ($)
item
Sep. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Apr. 30, 2016
USD ($)
Sep. 09, 2014
USD ($)
Summary Of Significant Accounting Policies                        
Number of product candidates under clinical development | item             1          
Royalty and milestone payments received     $ 240,500                  
Use of Estimates                        
Cash discount (as a percent)             2.00%          
Discount reimbursement period after filling of prescription subject to discount             1 month          
Recently Issued Accounting Standards                        
Benefit from income taxes       $ (513)   $ (6,042) $ (560) $ (17,692)        
Other assets, long-term       1,346     1,346   $ 1,458      
Convertible Notes       265,163     265,163   252,725      
Senior Notes       311,726     $ 311,726   466,051      
ASU 2016-09                        
Recently Issued Accounting Standards                        
Accumulated deficit $ (300)                      
Deferred tax assets related to share-based compensation                 5,800      
Valuation allowance for deferred tax assets                 5,800      
Minimum                        
Use of Estimates                        
Discount taken off period after the quarter in which product shipped to the customer             1 month          
Period after the quarter in which prescription is filled for paying rebate             2 months          
Minimum | Managed Care Rebates                        
Use of Estimates                        
Period after the quarter in which prescription is filled for rebate             1 month          
Minimum | Medicare Part D Coverage Gap Rebates                        
Use of Estimates                        
Period after the quarter in which prescription is filled for rebate             2 months          
Maximum                        
Use of Estimates                        
Product return period prior to expiration             6 months          
Period after expiration for accepting unsalable product             12 months          
Discount taken off period after the quarter in which product shipped to the customer             2 months          
Period after the quarter in which prescription is filled for paying rebate             3 months          
Maximum | Managed Care Rebates                        
Use of Estimates                        
Period after the quarter in which prescription is filled for rebate             3 months          
Maximum | Medicare Part D Coverage Gap Rebates                        
Use of Estimates                        
Period after the quarter in which prescription is filled for rebate             3 months          
NUCYNTA ER, NUCYNTA and Gralise                        
Use of Estimates                        
Rebates         $ 4,700       1,000      
NUCYNTA ER | Minimum                        
Use of Estimates                        
Product shelf-life             24 months          
NUCYNTA ER | Maximum                        
Use of Estimates                        
Product shelf-life             36 months          
NUCYNTA                        
Use of Estimates                        
Product shelf-life             36 months          
Gralise | Minimum                        
Use of Estimates                        
Product shelf-life             24 months          
Gralise | Maximum                        
Use of Estimates                        
Product shelf-life             36 months          
CAMBIA | Minimum                        
Use of Estimates                        
Product shelf-life             24 months          
CAMBIA | Maximum                        
Use of Estimates                        
Product shelf-life             48 months          
Zipsor                        
Use of Estimates                        
Product shelf-life             36 months          
Lazanda | Minimum                        
Use of Estimates                        
Product shelf-life             24 months          
Lazanda | Maximum                        
Use of Estimates                        
Product shelf-life             36 months          
Convertible Notes                        
Summary Of Significant Accounting Policies                        
Aggregate principal amount of notes issued       345,000     $ 345,000   345,000     $ 345,000
Recently Issued Accounting Standards                        
Convertible Notes                       $ 226,000
Senior Notes       265,163     265,163   252,725      
Senior Notes                        
Summary Of Significant Accounting Policies                        
Aggregate principal amount of notes issued   $ 575,000   375,000     375,000       $ 375,000  
Proceeds from the issuance of debt   $ 562,000                    
Recently Issued Accounting Standards                        
Senior Notes       $ 369,226     $ 369,226   $ 466,051      
Payments of Debt Issuance Costs                   $ 500